Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region

Mark S Segal, MD, PhD

Nephrologist (Kidney Specialist)

Photo of Mark S Segal

About me

I am the senior associate dean for faculty affairs and professional development for the University of Florida College of Medicine and a professor of medicine in the UF Division of Nephrology, Hypertension & Renal Transplantation. I love the long-term patient-doctor relationship and the quantitative element of nephrology. I treat patients with lupus nephritis, ANCA vasculitis, aHUS and patients who are pregnant and have kidney disease. I strive to help patient’s live long, fulfilling lives without the need of dialysis or kidney transplantation.

I received my Bachelor of Science from the Massachusetts Institute of Technology (MIT), and my MD/PhD degrees from the University of Texas Southwestern Medical School. I completed an internal medicine internship and residency at Parkland Memorial Hospital and a nephrology fellowship at Beth Israel Deaconess Medical Center in Boston. I am board certified in internal medicine and nephrology by the American Board of Internal Medicine.

My research has been funded continuously by the National Institutes of Health (NIH), and I study the mechanism of cardiovascular disease in unique patient populations. As a physician and a scientist, my goal is to remain a lifelong learner, always reassessing the best and most effective way to provide individualized care to my patients.

When not helping patients, I enjoy home renovation, gardening and cooking.

My locations

Active clinical trials

Regen-008S1

The purpose of this study is to evaluate the long-term safety of up to two gelatin-hydrogel formulation REACT injections given 3 to 6 months apart and delivered percutaneously into same kidney on renal function in participants with chronic kidney…

Investigator
Mark S Segal
Status
Accepting Candidates
Ages
30 Years - 80 Years
Sexes
All
REGEN-006

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-biopsied contralateral kidneys in participants with…

Investigator
Mark S Segal
Status
Accepting Candidates
Ages
30 Years - 80 Years
Sexes
All

My research

Top areas of exploration

  • Cells, Cultured , 20 publications
  • Hypertension , 17 publications
  • Biomarkers , 17 publications
  • Kidney Failure, Chronic , 16 publications

Research activity

177 publications

11,942 citations

Why is this important?
View more of Mark Segal's research activity

Accepted insurances

Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.

See all

My areas of focus

Stories and news

View more stories related to Mark Segal